Ranbaxy Laboratories has reported results for second quarter ended June 30, 2012.
On standalone basis, the company has reported a net loss of Rs 925.66 crore for the quarter ended June 30, 2012 against net profit of Rs 150.37 crore for the corresponding period last fiscal. However, total income increased by 22.23% at Rs 1586.98 crore during the quarter under review from Rs 1298.34 crore in the year-ago period.
On Consolidated basis, the company has reported a net loss of Rs 585.72 crore for the quarter ended June 30, 2012 against net profit of Rs 243.23 crore for the corresponding period last fiscal. However, total income increased by 54.82% at Rs 3298.21 crore during the quarter under review from Rs 2130.31 crore in the year-ago period.
